Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases.
Nazlıhan Boyacı DündarDavid SarphieKenan YüceÜmmügülsüm GaygısızO Tolga KaskatıMelda TürkoğluŞahender Gülbin Aygencel BıkmazLale KarabıyıkKayhan ÇağlarGulendam BozdayiRubina MianPaul MossMustafa Necmi İlhanPublished in: Intensive care medicine experimental (2023)
, shows that ROS production generally declined back to normal levels for patients who survived, but remained elevated for those patients who did not survive.